Cydan
Cambridge
About Cydan
Cydan is an orphan drug accelerator that identifies and de-risks compounds with therapeutic and commercial potential. Their rigorous process generates data to support a development path and new company formation. Cydan’s experienced and globally networked team brings strong relationships with academia and patient advocacy, deep expertise in drug development, and a track record of successful product commercialization.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $60.0M
- Last round: Series Unknown (Oct 2017)
- Website: cydanco.com
- Phone: 617-230-3010
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/cydan-22446 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.